• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 27, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

Majority of incontinence treatments deliver poor results

Bioengineer.org by Bioengineer.org
January 20, 2018
in Headlines, Health, Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Portrait photo: Magnus Gotander.

"Unfortunately we are not actually curing the condition in that many cases. Surgery aside, the results delivered are poor. And the problems are only going to get worse in the future because the population, as we know, is aging," says Ian Milsom, Professor of Gynecology and Obstetrics at the Sahlgrenska Academy and Head of the Gothenburg Continence Research Center (GCRC).

He and a group of researcher colleagues have together studied thousands of research articles and other scientific documentation written about different treatments of urinary and fecal incontinence in adults around the world, published between 2005 and 2015.

The sheer scope of the research makes this work unique. The researchers sifted through the mass of material using harmonized criteria and ultimately came up with percentages indicating how well or poorly different methods had worked. For the results to be considered successful, the individual must have been cured of incontinence three months after the treatment.

Surgery by Far the Best

Surgery ranks well ahead of other methods, delivering success in 82 percent of cases. Pelvic floor exercises rank second, with 53 percent, followed by drug treatment, with 49 percent.

Bottom of the pile was treatment using so-called bulking agents, which was only successful in 37 percent of cases. This method involves injections of fillers into damaged tissue around the urethra in order to keep the area tight.

Drugs are mainly prescribed to treat urinary incontinence and calm down overactive bladders. Ian Milsom finds it remarkable, including from a financial perspective, that these antimuscarinic drugs are not even helping half of all patients.

"The results don't look good at all considering the cost in billions that these drugs incur on health care systems. In contrast surgery on the other hand has become simpler and more effective and is delivering strong results even in the long term," he says.

Research Limping Along

Relatively few studies over the ten-year period focused on the elderly, despite their susceptibility to the condition. The same goes for people with neurological conditions. There were also insufficient studies into how individuals can live normal lives with incontinence by modifying their behavior and using catheters and absorbent protection.

Urinary and fecal incontinence have an impact on well-being and quality of life and sometimes lead to people feeling isolated in life, both professionally and socially. They also have an adverse effect on sexual health and, as far as the elderly as a group are concerned, increase the risk of institutionalization.

"This is a major issue for humans that we need to devote more research resources to, not just in Sweden but around the world. Five hundred million people on this planet are suffering from the condition; we need to improve treatment methods, not least for the elderly and those with neurological conditions, who it hits particularly hard," says Ian Milsom.

###

Link to article:http://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-017-0828-2

Head researcher: Professor Ian Milsom +46 (0)705 371 602; [email protected]

Press contact: Margareta Gustafsson Kubista +46 (0)705 301 980; [email protected]

Media Contact

Professor Ian Milsom
[email protected]
46-070-537-1602
@uniofgothenburg

http://www.gu.se/english

Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Revolutionary Wireless Metamaterial Spinal Implants Developed by Pitt Engineers and Surgeons: A Breakthrough in Healing and Communication

October 27, 2025
Cracking the Code of ‘Sticky’ Chemistry: A Path to Cleaner, More Efficient Fuels

Cracking the Code of ‘Sticky’ Chemistry: A Path to Cleaner, More Efficient Fuels

October 27, 2025

Multisystem Inflammatory Syndrome: SARS-CoV-2-Triggered Kawasaki Disease

October 27, 2025

Beyond Electronics: Utilizing Light to Accelerate Computing Technology

October 27, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1286 shares
    Share 514 Tweet 321
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    310 shares
    Share 124 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    197 shares
    Share 79 Tweet 49
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    134 shares
    Share 54 Tweet 34

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Revolutionary Wireless Metamaterial Spinal Implants Developed by Pitt Engineers and Surgeons: A Breakthrough in Healing and Communication

Cracking the Code of ‘Sticky’ Chemistry: A Path to Cleaner, More Efficient Fuels

Multisystem Inflammatory Syndrome: SARS-CoV-2-Triggered Kawasaki Disease

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 67 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.